CELDAZ 200MG INJECTION contains Dacarbazine which belongs to the group of medicines called Anticancer Agents. It is used to manage certain types of skin cancer (such as metastatic melanoma) and lymph cancer (such as Hodgkin’s disease). It can also be used in the management of soft tissue sarcoma (cancer of connective tissues).
Before receiving CELDAZ 200MG INJECTION inform your doctor if you have any liver or kidney problems. You must also inform your doctor if you have low WBC and platelet counts in blood or currently receiving radiotherapy as a precaution. Avoid consumption of alcohol while undergoing therapy with this medicine.
CELDAZ 200MG INJECTION is not recommended for use in pregnant or breastfeeding women. Both men and women of childbearing potential must use a suitable contraceptive to avoid pregnancy while undergoing therapy with this medicine and until 6 months after the last dose.
The common side effects associated with the use of CELDAZ 200MG INJECTION are nausea, vomiting, flu-like symptoms, nerve damage and low RBC, WBC and platelet counts causing tiredness, pale skin, increased infections, fever, sore throat, chills and increased bleeding or bruising. Consult your doctor if any of these side effects troubles you.
No content available
